Mª DEL CARMEN
VIDAL PAN
Profesora titular de universidade
Hospital Clinic Barcelona
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Clinic Barcelona (24)
2024
-
Profile of Patients With Moderate-to-Severe Atopic Dermatitis and Chronic Urticaria Undergoing Biological Treatment in Hospital Allergy Units in Spain: First Report of the Alergodata Registry
Journal of investigational allergology & clinical immunology, Vol. 34, Núm. 2, pp. 131-133
2023
-
ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482
2022
-
Efficacy of subcutaneous house dust mite immunotherapy in patients with moderate to severe allergic rhinitis
Immunotherapy, Vol. 14, Núm. 9, pp. 683-694
-
Major Allergen Content in Allergen Immunotherapy Products: The Limited Value of Numbers
Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 5, pp. 345-356
2021
-
Seaic specialty forum: Analysis of the current situation of allergology in spain and outlook for the future
Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 2, pp. 120-131
2019
-
Changes in mammographic density over time and the risk of breast cancer: An observational cohort study
Breast, Vol. 46, pp. 108-115
2018
-
Safety and Quality Recommendations in Allergy Medicine (Spanish acronym, RESCAL)
Journal of investigational allergology & clinical immunology, Vol. 28, pp. 1-39
2016
-
Allergy immunotherapy across the life cycle to promote active and healthy ageing: From research to policies
Clinical and Translational Allergy, Vol. 6, Núm. 1
2014
-
Diagnosis and allergen immunotherapy treatment of polysensitised patients with respiratory allergy in Spain: An Allergists' Consensus
Clinical and Translational Allergy, Vol. 4, Núm. 1
2013
-
Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes
Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 9, pp. 1994-2002
-
Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies
AIDS, Vol. 27, Núm. 1, pp. 81-85
2012
-
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy
Retrovirology, Vol. 9
-
Diagnosis and treatment of allergic rhinitis due to house-dust mites in Spain
American Journal of Rhinology and Allergy, Vol. 26, Núm. 1, pp. 23-26
-
Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaire
Respiratory Research, Vol. 13
2002
-
Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors
Journal of Acquired Immune Deficiency Syndromes, Vol. 29, Núm. 5, pp. 429-434
2001
2000
-
Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection
AIDS, Vol. 14, Núm. 13, pp. 1921-1933
-
Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus- infected patients receiving antiretroviral therapy
Clinical Infectious Diseases, Vol. 30, Núm. 2, pp. 392-394
1999
1998
-
Lack of evidence of a stable viral load set-point in early stage asymptomatic patients with chronic HIV-1 infection
AIDS, Vol. 12, Núm. 11, pp. 1285-1289